The National Data Bank for Rheumatic Diseases has conducted safety registries for Centocor, Sanofi-Aventis, and Bristol-Myers Squibb, and has received research grants from Abbott, Amgen, Wyeth-Australia, Merck, and Pfizer.
1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Rheumatoid Arthritis Clinical Studies
You have full text access to this OnlineOpen article
The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case–control analysis†
Article first published online: 29 AUG 2008
DOI: 10.1002/art.23811
Copyright © 2008 by the American College of Rheumatology
Additional Information
How to Cite
Wolfe, F. and Michaud, K. (2008), The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: A cohort and nested case–control analysis. Arthritis & Rheumatism, 58: 2612–2621. doi: 10.1002/art.23811
- †
Publication History
- Issue published online: 29 AUG 2008
- Article first published online: 29 AUG 2008
- Manuscript Accepted: 29 MAY 2008
- Manuscript Received: 27 AUG 2007
Funded by
- Abbott
- Amgen
- Wyeth-Australia
- Merck
- Pfizer
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , Managing cardiovascular risk in patients with chronic inflammatory diseases, Clinical Rheumatology, 2012, 31, 4, 585
- 2, , Risk factors for cardiovascular disease in rheumatoid arthritis, Current Opinion in Rheumatology, 2012, 24, 2, 171
- 3, , , , , Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis, Arthritis & Rheumatism, 2012, 64, 1Direct Link:
- 4, , Cardiovascular disease risk in rheumatoid arthritis: Progress, debate, and opportunity, Arthritis Care & Research, 2011, 63, 4Direct Link:
- 5, , Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model, Rheumatology International, 2011,
- 6, , , , , Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review, Joint Bone Spine, 2011, 78, 1, 23
- 7, , , Cardiovascular safety of biologic therapies for the treatment of RA, Nature Reviews Rheumatology, 2011, 8, 1, 13
- 8, , Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE, Nature Reviews Rheumatology, 2011, 7, 7, 399
- 9, , , , Impact of comorbidities on TNF inhibitor persistence in rheumatoid arthritis patients: an analysis of Korean National Health Insurance claims data, Rheumatology International, 2011,
- 10, , Kardiovaskuläre Komorbidität und ihre Risikofaktoren bei rheumatoider Arthritis, Zeitschrift für Rheumatologie, 2011, 70, 6, 464
- 11, , , , , , No Increased Risk of Myocardial Infarction Among Patients With Ulcerative Colitis or Crohn's Disease, Clinical Gastroenterology and Hepatology, 2011, 9, 10, 875
- 12, , , , , , Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis, Arthritis Care & Research, 2011, 63, 2Direct Link:
- 13, , , , , , , Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease, The American Journal of Cardiology, 2011, 108, 9, 1362
- 14, , , , , , , , , , , , , , , , , , A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries, Seminars in Arthritis and Rheumatism, 2010, 40, 1, 2
- 15, Cardiovascular adverse reactions from NSAIDs are more than COX-2 inhibition alone, Rheumatology, 2010, 49, 5, 834
- 16, , Cardiovascular disease in rheumatoid arthritis: a step forward, Current Opinion in Rheumatology, 2010, 22, 3, 342
- 17, , , , , , , , , , , , , , , , , , , , , , , , , Development and initial validation of a self-assessed lupus organ damage instrument, Arthritis Care & Research, 2010, 62, 4Direct Link:
- 18, , , , Epidemiology of Rheumatoid Arthritis: Rheumatoid Arthritis and Mortality, Current Rheumatology Reports, 2010, 12, 5, 379
- 19
- 20, , , , , Risque cardiovasculaire associé à la corticothérapie à faible dose dans la polyarthrite rhumatoïde : revue de la littérature, Revue du Rhumatisme, 2010, 77, 6, 542
- 21, , , , , , , The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases, Autoimmunity Reviews, 2010, 9, 12, 835
- 22, , The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank, Rheumatology, 2010, 50, 1, 16
- 23, , , , , , , , , Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review, Rheumatology, 2010, 50, 3, 518
- 24
- 25, Management of cardiovascular disease risk in chronic inflammatory disorders, Nature Reviews Rheumatology, 2009, 5, 4, 208
- 26, Progression in early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 59
- 27, , , , Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity, The Cochrane Library,Direct Link: